Eli Lilly obesity pill disappoints in trial, sending shares down 14%

1 year ago 197
Weight loss comes in at lower end of expectations and triggers stock boost for rival Novo Nordisk
Read Entire Article
  1. Homepage
  2. Latest News
  3. Eli Lilly obesity pill disappoints in trial, sending shares down 14%

Related

'We got penalised for saying 'pregnancy' on Instagram'

51 minutes ago 2

Your child wasn't invited to the party - here's how to handl...

59 minutes ago 2

Same-day test helps doctors detect hidden infections in crit...

1 hour ago 1

Trending

Popular

pewresearch - Methodology

1 year ago 1207

foreignaffairs - Europe Needs a New Way to Cooperate

1 year ago 1144

ft - Mission impossible? Abel faces tricky task leading Berkshire...

1 year ago 1127

csmonitor - Hiring is up, GDP is down: Economy sends mixed signals as ta...

1 year ago 1075

newsnationnow - PBS CEO: New children's programming will 'skid to a halt' un...

1 year ago 985
English (US) English (US) ·
About Us · Terms & Conditions ·

© Crazysimon 2026. All rights are reserved